2011/09/13
BDA advises Pfizer on JV with Jilin Guoyuan Animal Health
established an animal vaccine JV with Jilin Guoyuan Animal Health
2011
Recent transactions
divested majority stake in
to
2024
acquired majority stake in
2024
has been acquired by
2023
received investment from
2023
a subsidiary of
has acquired
2022
a portfolio company of
has been acquired by
2022
agreed to divest East Syracuse, New York facility to
2022
has sold minority stake to
2022
出售给Novo Holdings
2022
investment from
2021
has been acquired by
2021
a portfolio company of
has been acquired majority stake by
2021
拟出售给迈瑞医疗
2021
divested majority stake to
DCP Capital
2021
agreed to divest Couvet, Switzerland facility to WuXi AppTec
2021
raised Series B round from
2021
出售尼奥斯给松柏投资
2020
divested Escientia Life Sciences to Deccan Fine Chemicals
2020
divested significant stake in
Kehua Bio-Engineering to Gree Real Estate
2020
majority sale
2019